Psychiatric Symptoms for COVID-19 Registry Japa
- Conditions
- Post COVID-19 conditionLong COVIDD000086402
- Registration Number
- JPRN-jRCT1030220711
- Lead Sponsor
- Kito Shinsuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Patients (16 years of age or older, regardless of diagnosis or gender) who have received care at a medical institution approved to participate in this study as a collaborating institution due to COVID-19 infection, who have psychiatric symptoms after infection, and who have given written consent for enrollment in this registry. Minors and persons lacking the capacity to consent will be included in this study. If minors or persons lacking the capacity to consent wish to participate in the study, consent shall be obtained from the person himself/herself as well as from a substitute consenting party. In the first year of the study, minors under 16 years of age will not be included, and for minors under 18 years of age, consent will be obtained from the individual and a surrogate.
As for the non-infected control group, healthy subjects obtained in the previous research project Elucidation of Diversity and Age-related Changes in Neural Circuitry in the Human Brain at Nagoya University will be included.
Those who are unable to obtain the consent of the patient or those whose participation in this study is deemed inappropriate by the attending physician, such as those whose medical condition is expected to worsen as a result of participating in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method